Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Research Center for Intestinal Health Science, Okayama University, Okayama, Japan.
J Bacteriol. 2024 Oct 24;206(10):e0030724. doi: 10.1128/jb.00307-24. Epub 2024 Sep 5.
The lipopeptide antibiotic daptomycin exhibits bactericidal activity against Gram-positive bacteria by forming a complex with phosphatidylglycerol (PG) and lipid II in the cell membrane, causing membrane perforation. With the emergence of daptomycin-resistant bacteria, understanding the mechanisms of bacterial resistance to daptomycin has gained great importance. In this study, we aimed to identify the genetic factors contributing to daptomycin resistance in , a model Gram-positive bacterium. Our findings demonstrated that overexpression of , which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in . Specifically, overexpression of resulted in increased levels of diglucosyldiacylglycerol (GlcDAG) and decreased levels of acidic phospholipids cardiolipin and PG, as well as the basic phospholipid lysylphosphatidylglycerol. However, overexpression did not alter the cell surface charge and the susceptibility to the cationic antimicrobial peptide nisin or the cationic surfactant hexadecyltrimethylammonium bromide. Furthermore, by serial passaging in the presence of daptomycin, we obtained daptomycin-resistant mutants carrying mutations. These mutants showed increased levels of GlcDAG and a >4-fold increase in the minimum inhibitory concentration of daptomycin. These results suggest that increased GlcDAG levels, driven by overexpression, modify the phospholipid composition and confer daptomycin resistance in without altering the cell surface charge of the bacteria.IMPORTANCEDaptomycin is one of the last-resort drugs for the treatment of methicillin-resistant infections, and the emergence of daptomycin-resistant bacteria has become a major concern. Understanding the mechanism of daptomycin resistance is important for establishing clinical countermeasures against daptomycin-resistant bacteria. In the present study, we found that overexpression of , which encodes diglucosyldiacylglycerol synthase, induces daptomycin resistance in , a model Gram-positive bacteria. The overexpression of increased diglucosyldiacylglycerol levels, resulting in altered phospholipid composition and daptomycin resistance. These findings are important for establishing clinical strategies against daptomycin-resistant bacteria, including their detection and management.
达托霉素是一种脂肽类抗生素,通过与细胞膜中的磷脂酰甘油 (PG) 和脂质 II 形成复合物,导致膜穿孔,从而对革兰氏阳性菌表现出杀菌活性。随着耐达托霉素细菌的出现,了解细菌对达托霉素耐药的机制变得尤为重要。在这项研究中,我们旨在确定 ,一种革兰氏阳性模式菌,中导致达托霉素耐药的遗传因素。我们的研究结果表明,二葡糖基二酰基甘油合酶编码基因 的过表达可诱导 对达托霉素产生耐药性。具体来说, 的过表达导致二葡糖基二酰基甘油 (GlcDAG) 水平升高,而心磷脂和 PG 等酸性磷脂以及赖氨酸磷酸甘油酯等碱性磷脂水平降低。然而, 的过表达并未改变细胞表面电荷以及对阳离子抗菌肽乳链菌肽或阳离子表面活性剂十六烷基三甲基溴化铵的敏感性。此外,通过在达托霉素存在下进行连续传代,我们获得了携带 突变的达托霉素耐药突变体。这些突变体显示 GlcDAG 水平升高,达托霉素的最小抑菌浓度增加了 >4 倍。这些结果表明,由 过表达驱动的 GlcDAG 水平升高改变了磷脂组成,并在不改变细菌表面电荷的情况下赋予 对达托霉素的耐药性。
达托霉素是治疗耐甲氧西林 感染的最后手段之一,耐达托霉素细菌的出现已成为一个主要关注点。了解达托霉素耐药的机制对于制定针对耐达托霉素细菌的临床对策非常重要。在本研究中,我们发现,二葡糖基二酰基甘油合酶编码基因 的过表达可诱导革兰氏阳性模式菌 对达托霉素产生耐药性。 的过表达增加了二葡糖基二酰基甘油的水平,导致磷脂组成改变和达托霉素耐药。这些发现对于制定针对耐达托霉素细菌的临床策略(包括检测和管理)非常重要。